Timothy Pluard, MD, Receives Outstanding Achievement Award from National Cancer Institute

Timothy Pluard, MD

The National Cancer Institute (NCI) has recognized Timothy Pluard, MD, an assistant professor of medicine at Washington University School of Medicine, as a top enroller of cancer patients in clinical trials.

Pluard is medical director of the Siteman Cancer Center at Barnes-Jewish St. Peters Hospital.

The award, a Certificate of Outstanding Achievement from the NCI's Cancer Trials Support Unit, recognizes Pluard and his team's work recruiting for NCI's Clinical Trials Cooperative Group Program in 2012.

Clinical trials are research studies designed to find new ways to diagnose, treat or prevent a disease. The studies are the final step in research before a new therapy is approved for broad use. Clinical trials are especially important in the fight against cancer.

The Siteman Cancer Center, the only NCI-designated Comprehensive Cancer Center in Missouri, is ranked a top 10 cancer facility by U.S. News & World Report. Comprising the cancer research, prevention and treatment programs of Barnes-Jewish Hospital and Washington University School of Medicine, Siteman is also Missouri's only member of the National Comprehensive Cancer Network. For more information, visit www.siteman.wustl.edu or call 314-747-7222 or 800-600-3606 toll free.

Barnes-Jewish St. Peters Hospital provides comprehensive inpatient and outpatient services that include the Siteman Cancer Center at Barnes-Jewish St. Peters Hospital, the Cardiology Center and the Outpatient Surgery and Endoscopy Center.  In 2012, Consumer Reports magazine rated this 113-bed community hospital as one of the safest in the St. Louis metropolitan area and in the state of Missouri based on its review of publicly available patient safety and quality data.  For more information visit www.bjsph.org.